Work

Alpha-emitting bismuth cyclohexylbenzyl DTPA constructs of recombinant humanized anti-CD33 antibodies: pharmacokinetics, bioactivity, toxicity and chemistry.

Year: 1999

Type: article

Source: PubMed

Authors: T K Nikula, M R McDevitt, R D Finn, C Wu, R W Kozak, K Garmestani, M W Brechbiel, M J Curcio, C G Pippin, L Tiffany-Jones, M W Geerlings, C Apostolidis, R Molinet, M W Geerlings, O A Gansow, D A Scheinberg

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: Improving specificity of therapeutic antibodies for cancer., Targeted antigen receptor treatment of cancer, RADIOIMMUNOTHERAPY IN CHRONIC MYELOGENOUS LEUKEMIA

OpenAlex ID: W2123987346

FWCI: 10.09

Cites: 38

Cited by: 176

Related to: 10